LTRN
#4398
Lantern Pharma Inc. - Common Stock
3.4 6 USD
-0.04%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.89%
Variación mensual
-13.72%
Variación en los últimos 6 meses
-2.26%
Cambio anual
-17.42%
Cierres anteriores
3.6 0
Open
3.4 6
Mínimo
3.4 6
High
3.4 6
Volumen
7
Financials
- Market Capitalization 39.11 M
- Employee 16
- Founded 2013
- CEO N/A
- Website www.lanternpharma.com
- Headquarter Texas, United States
- FIGI BBG00GM6LK17
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.93
Relación precio/flujo de caja
-390.6
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4384 |  RNXT RenovoRx, Inc. - Common Stock | 0.91 USD | -2.15% | -2.15% | +8.33% | -34.06% | 41.04 M USD | ||
| 4395 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.43 USD | -0.82% | -4.33% | +10.45% | -38.94% | 39.55 M USD | ||
| 4412 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.88 USD | -6.38% | -13.73% | -20.72% | +3.53% | 37.87 M USD | ||
| 4417 |  DYAI Dyadic International, Inc. - Common Stock | 1.02 USD | -3.77% | +6.25% | +43.66% | +2.00% | 37.17 M USD |